Barcelona, Spain

Nuria Recasens


Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1995-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Nuria Recasens: Pioneering Research in Pharmaceutical Compounds

Introduction

Nuria Recasens, an accomplished inventor based in Barcelona, Spain, has made significant contributions to the field of pharmaceuticals. With three patents to her name, her innovative research focuses on developing compounds that offer therapeutic advantages in treating various diseases.

Latest Patents

One of Recasens' most notable patents is centered around Piperidine derivatives with PAF antagonist activity. This invention specifically addresses the treatment of diseases mediated by PAF and histamine. The patent describes 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, which is recognized as a dual PAF antagonist and antihistamine. The patent not only outlines the compound's structure but also includes a process for its preparation and pharmaceutical compositions that incorporate it, reflecting Recasens' commitment to advancing medical science through innovation.

Career Highlights

Nuria Recasens is currently employed at J. Uriach & Cia, S.A., where she continues to focus on her groundbreaking research. Her work is characterized by an emphasis on developing pharmaceuticals that can significantly impact patient care and treatment outcomes. With her expertise in medicinal chemistry and pharmacology, Recasens has positioned herself as a key player in her field.

Collaborations

Throughout her career, Recasens has collaborated with several professionals, including notable colleagues such as Elena Carceller and Carmen Almansa. This collaborative spirit not only enhances the richness of her research but also fosters a working environment of shared knowledge and innovation.

Conclusion

Nuria Recasens exemplifies the spirit of innovation within the pharmaceutical industry. With her significant patent portfolio and collaborative efforts, she continues to drive forward the understanding and treatment of complex diseases. Her work serves as an inspiring testament to the power of research and innovation in improving health outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…